Transphorm, Inc. (TGAN)
Stock Price:
$3.50 USD
0.00 (0.00%)
Updated Oct 21, 2020 2:38 PM EDT - Market closed
Key Info
| Market Cap |
122.97M |
| Revenue (ttm) |
18.83M |
| Net Income (ttm) |
-15.36M |
| Shares Out |
35.14M |
| EPS (ttm) |
-3.58 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 21, 2020 |
| Last Price |
$3.50 |
| Previous Close |
$3.50 |
| Change ($) |
0.00 |
| Change (%) |
0.00% |
| Day's Open |
3.50 |
| Day's Range |
3.50 - 3.50 |
| Day's Volume |
500 |
| 52-Week Range |
3.5 - 50 |
More Stats
| Market Cap |
122.97M |
| Enterprise Value |
149.93M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
35.14M |
| Float |
13.37M |
| EPS (basic) |
-3.58 |
| EPS (diluted) |
-3.58 |
| FCF / Share |
0.00 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
0.04% |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
2,235.90 |
| PS Ratio |
6.53 |
| PB Ratio |
n/a |
| Revenue |
18.83M |
| Operating Income |
-11.28M |
| Net Income |
-15.36M |
| Free Cash Flow |
55,000 |
| Net Cash |
-26.96M |
| Net Cash / Share |
-0.77 |
| Gross Margin |
29.66% |
| Operating Margin |
-59.88% |
| Profit Margin |
-81.50% |
| FCF Margin |
0.29% |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
-141.70% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$8.00*
(128.57% upside)
Low
8.00
Current: $3.50
High
8.00
Target: 8.00
*Average 12-month price target from 2 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | 11.93 | 1.36 |
| Revenue Growth | 778.79% | - |
| Gross Profit | 5.44 | -3.24 |
| Operating Income | -11.92 | -21.90 |
| Net Income | -15.28 | -25.80 |
| Shares Outstanding | 4.22 | 4.22 |
| Earnings Per Share | -3.62 | -6.11 |
| Operating Cash Flow | -12.29 | -17.69 |
| Capital Expenditures | -0.20 | -0.33 |
| Free Cash Flow | -12.49 | -18.02 |
| Cash & Equivalents | 2.88 | 3.07 |
| Total Debt | 41.63 | 26.20 |
| Net Cash / Debt | -38.75 | -23.13 |
| Assets | 10.26 | 10.50 |
| Liabilities | 46.86 | 32.38 |
| Book Value | -122 | -108 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Transphorm, Inc. |
| Country |
United States |
| Employees |
100 |
| CEO |
Mario A. Rivas |
Stock Information
| Ticker Symbol |
TGAN |
| Stock Exchange |
US OTC |
| Sector |
Technology |
| Industry |
Semiconductor Equipment & Materials |
| Unique Identifier |
OTCMKTS: TGAN |
Description
Transphorm designs and manufactures gallium nitride (GaN) field effect transistors. It offers products for various high-voltage power conversion applications, such as server/storage products, PV inverters, automotive products, and motor control. The company offers products through sales representatives and distributors in the Americas, the EMEA, Japan, China and ASEAN, Korea, and Taiwan. Transphorm, Inc. was founded in 2007 and is based in Goleta, California.